Medicated chitin fiber for treating and preventing proliferation of mammary gland, prepn. method and application thereof
A technology of chitosan fiber and mammary gland hyperplasia, which is applied in the field of medicinal fiber, can solve problems such as strong odor, and achieve the effect of simple production process, easy realization, and small side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0023] A kind of preparation method of the medicinal chitosan fiber of prevention and treatment mammary gland hyperplasia:
[0024] The first step is to prepare spinning dope. The chitosan-containing spinning dope is firstly prepared according to the existing technology, and each component is calculated by weight percentage, wherein the dry solid content of the chitosan is 99%. Then the medicine for preventing and treating mammary gland hyperplasia and the drug transdermal absorption accelerator are added in the spinning stock solution and stirred evenly. 0.5%;
[0025] The second step is to make medicinal chitosan fibers from the spinning stock solution containing anti-mammary gland hyperplasia drugs and drug transdermal absorption accelerators, and use wet spinning technology to make medicinal chitosan fibers that contain both shell Polysaccharides also contain drugs for preventing and treating mammary gland hyperplasia and drug transdermal absorption accelerators;
[002...
Embodiment 2
[0033] In the present embodiment, the dry solid content of chitosan in the spinning dope is 80%, the dry solid content of the anti-mammary gland hyperplasia medicine is 15%, and the dry solid content of the drug transdermal absorption accelerator is 5%.
[0034] The method is that the medicinal chitosan fiber is prepared from the spinning stock solution containing the drug for preventing and treating mammary gland hyperplasia and the drug transdermal absorption accelerator, and adopts a dry spinning process.
Embodiment 3
[0036] In this embodiment, the dry solid content of chitosan in the spinning dope is 70%, the dry solid content of the drug for preventing and treating mammary gland hyperplasia is 20%, and the dry solid content of the drug transdermal absorption accelerator is 10%.
[0037] The method is that the medicinal chitosan fiber is prepared from the spinning stock solution containing the anti-mammary gland hyperplasia drug and the transdermal absorption accelerator of the drug, and adopts a dry jet wet spinning process.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com